India’s primary market braces for surge of hospital and IVF IPOs next year

India’s primary market anticipates a significant influx of healthcare IPOs next year, with an estimated ₹20,000 crore in public issues expected. Major hospital chains like Manipal Hospitals and IVF platforms such as Indira IVF are preparing to list, driven by strong fundamentals and favorable valuations. This surge reflects the sector’s growth momentum and attractive opportunities […]

RBI doubles liquidity injection to Rs 1.5 lakh crore ahead of tax payments

The Reserve Bank of India is injecting Rs 1.5 lakh crore into the financial system. This move aims to prevent any cash crunch as advance tax and GST payments are due. The central bank is conducting a dollar-rupee buy-sell swap to add more liquidity. This action will help keep overnight interest rates stable.

RBI doubles liquidity injection to Rs 1.5 Lakh crore ahead of tax payments

The Reserve Bank of India is injecting Rs 1.5 lakh crore into the financial system. This move aims to prevent any cash crunch as advance tax and GST payments are due. The central bank is conducting a dollar-rupee buy-sell swap to add more liquidity. This action will help keep overnight interest rates stable.

NCDEX gets Sebi nod for mutual fund platform ahead of equity launch

National Commodity & Derivatives Exchange Ltd, NCDEX, has received in-principle approval from Sebi to launch a mutual fund transaction platform. This platform will enable investors to subscribe to and redeem mutual fund units. The exchange aims to expand financial inclusion by targeting rural and semi-urban areas with low-denomination systematic investment plans.

2 top stock recommendations from Rajesh Bhosale

Indian equity markets rebounded on Monday, led by banking stocks, after testing key support levels. While the near-term bias remains positive, the market is expected to trade within a narrow range. Experts see improving technical signals in broader markets and recommend a selective buy-on-dips strategy, highlighting opportunities in IDFC First Bank and Britannia.

Amish Shah turns bullish on pharma, remains cautious on IT

Indian equities are poised for a constructive phase, with strategists anticipating earnings acceleration and a potential revival in foreign investor interest. While near-term earnings surprises are limited, FY27 is projected to see significant growth. Pharma is favored over IT, with selective opportunities in midcaps and other sectors.